53 /100
HIGH RISK
Score updated Apr 13, 2026

ENGN

enGene Therapeutics Inc. — Stock Dilution Tracker

Track ENGN dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

🔔 Track ENGN — Get alerts when the score changes →
📊 Score Breakdown
📋 Offering Ability
85
💰 Cash Runway
0
📊 Float Risk
62
⚠️ Warrant Exposure
15
🔄Convertible Debt
🌦️ Dilution Forecast
Watch
Minor dilution signals detected
23%
💰 Capital Raise 38%
• Active shelf registration ($400M, 83% of market cap)
• Active ATM program with $100M remaining capacity
🔁 Convertible Conversion 15%
• Convertible debt present: 7.9% potential dilution
🔔 Track ENGN — Get forecast alerts →
💹 Market Data
Market Cap$482.32M
Shares Outstanding66.99M
Float26.44M
Cash$275.95M
Debt$33.46M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↑ 54.2% shares (2025Q4 vs prior)
59 institutional holders · 63.02M shares
#1 FCPM III SERVICES B.V. 9.63M shares
#2 Blue Owl Capital Holdings LP 6.72M shares
#3 PERCEPTIVE ADVISORS LLC 5.87M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest1.15M
Days to Cover4.1
% of Float4.3%
FINRA data as of Mar 31, 2026
📁 Recent SEC Activity
xbrl XBRL WARRANT Oct 31, 2024
xbrl XBRL CONVERTIBLE Oct 31, 2023
424B5 ATM Mar 09, 2026
8-K 8K EVENT Mar 09, 2026
EFFECT EFFECT Mar 02, 2026
Full SEC filing analysis available with free account
📰 Recent News
No recent news
Track ENGN Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking ENGN — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required